Key Findings
The Europe blood plasma market is predicted to record growth, at a CAGR of 6.39% during the forecast period. The growing geriatric population and the increasing cases of immunodeficiency diseases, are the major drivers of market growth.

Market Insights
The Europe blood plasma market growth assessment involves the market analysis of Russia, Germany, the United Kingdom, Italy, Belgium, Poland, France, and the rest of Europe. Germany was one of the major countries to record the highest rate of blood plasma donations through apheresis. There has been an increasing number of sports injuries that affect areas like joints or tendons. Such factors have resulted in the widespread use of blood plasma procedure due to its varied benefits. There is an increasing prevalence of osteoarthritis in Italy, leading to increased demands for blood plasma. Also, the use of polyvalent immunoglobulins that are administered through the subcutaneous route has grown over the years as a result of increasing preference for self-infusion by patients. In Russia, the rising aging population, and the resultant demand for a strong healthcare system, are set to boost market growth. The countries in the rest of Europe segment make use of blood plasma treatment for cosmetic and sports medicine treatment.

Competitive Insights
Some of the renowned companies in the market include, Grifols, Kedrion Biopharma Inc, Octapharma, Biotest AG, Cerus Corporation (Cerus), etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments